succinic acid has been researched along with fluorouracil in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, JM; Naider, F; Steinfeld, AS | 1 |
| Hall, IH; Ibuka, T; Kim, HL; Kiyokawa, H; Lee, KH; Muraoka, O; Sims, D | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cheng, GY; Cheng, SY; Chui, CH; Gambari, R; Kok, SH; Lam, KH; Lam, PL; Lee, KK; Wong, RS; Yuen, MC | 1 |
4 other study(ies) available for succinic acid and fluorouracil
| Article | Year |
|---|---|
Anticandidal activity of 5-fluorocytosine-peptide conjugates.
Topics: Antifungal Agents; Candida; Cytosine; Drug Stability; Esters; Flucytosine; Hydrolysis; Microbial Sensitivity Tests; Oligopeptides; Saccharomyces cerevisiae | 1979 |
Antitumor agents. 44. Bis(helenalinyl) esters and related derivatives as novel potent antileukemic agents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Evaluation; Leukemia, Experimental; Mice; Sesquiterpenes; Structure-Activity Relationship | 1981 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Development of hydrocortisone succinic acid/and 5-fluorouracil/chitosan microcapsules for oral and topical drug deliveries.
Topics: Administration, Oral; Administration, Topical; Animals; Capsules; Chitosan; Drug Delivery Systems; Fluorouracil; Hydrocortisone; Keratinocytes; Mice; Skin; Staphylococcus aureus; Succinic Acid | 2012 |